Nuzenio

Gyre Therapeutics

Gyre Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 03:37:39 GMTGyre Therapeutics (NASDAQ:GYRE) Issues Earnings Results - MarketBeat
Fri, 07 Aug 2026 21:03:24 GMTGYRE: Net loss widened to $32.8 million on $53.5 million revenue, with strong liquidity maintained - TradingView
Fri, 07 Aug 2026 21:01:46 GMTGyre Therapeutics (NASDAQ: GYRE) swings to 32,849 H1 2026 net loss - Stock Titan
Fri, 07 Aug 2026 18:05:06 GMTGyre Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Fri, 07 Aug 2026 17:57:54 GMTGyre Therapeutics Inc (GYRE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 07 Aug 2026 17:25:43 GMTH.C. Wainwright Maintains Gyre Therapeutics(GYRE.US) With Buy Rating, Maintains Target Price $18 - Moomoo

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gyre Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.